- £954.54m
- £2.23bn
- £1.51bn
- 42
- 49
- 92
- 68
Annual balance sheet for Spire Healthcare, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 106 | 203 | 74.2 | 49.6 | 43.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 83.1 | 80.8 | 84.8 | 99.7 | 105 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 245 | 342 | 219 | 220 | 224 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,535 | 1,554 | 1,584 | 1,619 | 1,663 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,105 | 2,237 | 2,160 | 2,288 | 2,343 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 254 | 302 | 283 | 318 | 342 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1,398 | 1,528 | 1,429 | 1,548 | 1,595 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 707 | 710 | 731 | 740 | 748 |
| Total Liabilities & Shareholders' Equity | 2,105 | 2,237 | 2,160 | 2,288 | 2,343 |
| Total Common Shares Outstanding |